PharmaBoardroom

Interview with Michael Sean Reilly, General Manager for…

Michael Sean Reilly: General Manager for Pharmaceuticals Juan Carlos Berbessi: Medical Director Maria del Pilar Rubio: Medical Manager for Vaccines…

Interview with Andreas Fibig, CEO, Bayer Schering Pharma

The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this…

Interview with Christian Quiroga, General Manager, Baxter Chile

Baxter Chile established itself in the country through the acquisition of a local manufacturer in 1995. What have been the main challenges for the…

Interview with Cesar Rengifo, President, GSK Brazil

You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and…

Interview with Rolf E. Hoenger, General Manager, Productos Roche…

What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all…

Interview with Leonard Ariff Abdul Shatar, President, Malaysian…

The pharmaceutical industry has been targeted as one of the key growth sectors for the Malaysian economy under the 10th Malaysia Plan, how successful…

Interview with Johannes Setijono , President Commissioner, Kolbe

You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company…

Interview with Riette Blacquiere, Executive Officer, The American…

How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to operate from the committee perspective,…

Interview with Zenaida Balajadia, Chairman of the board, Lloyd…

Ms Balajadia, you founded Lloyd Laboratories in 1989. What was the driving force behind the establishment of the company? Truth is, when we started…

Interview with Maurits Huigen, General Manager, Chiesi…

The Dutch affiliate of Chiesi was established in 2007 when many changes were occurring in the local industry. The new healthcare system policy went…

Interview with P.F. Bongers, Chairman, Bogin

Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the…

Interview with Tamàs Dàvid, Deputy Director & Market…

With various new government measures, the pharmaceutical and healthcare sector in Hungary has been undergoing quite a turbulent period recently. But…

Tagged with